RHI Magnesita N.V. (FRA:RHF)

Intra-Cellular Therapies Revenue

RHI Magnesita had revenue of 1.68B EUR in the half year ending June 30, 2025, a decrease of -3.29%. This brings the company's revenue in the last twelve months to 3.44B, down -3.64% year-over-year. In the year 2024, RHI Magnesita had annual revenue of 3.49B, down -2.38%.

• Revenue (ttm): 3.44B
• Revenue Growth: -3.64%
• P/S Ratio: 0.36
• Revenue / Employee: 171.80K
• Employees: 29,431
• Market Cap: 1.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.49B	-85.00M	-2.38%
Dec 31, 2023	3.57B	254.80M	7.68%
Dec 31, 2022	3.32B	765.80M	30.01%
Dec 31, 2021	2.55B	292.40M	12.94%
Dec 31, 2020	2.26B	-663.30M	-22.70%